News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
529,703 Results
Type
Article (33604)
Company Profile (180)
Press Release (495919)
Section
Business (154905)
Career Advice (730)
Deals (25253)
Drug Delivery (61)
Drug Development (59575)
Employer Resources (78)
FDA (14224)
Job Trends (11868)
News (259423)
Policy (24121)
Tag
Academia (2284)
Alliances (43188)
Alzheimer's disease (912)
Approvals (14175)
Artificial intelligence (132)
Bankruptcy (204)
Best Places to Work (9652)
Biotechnology (133)
Breast cancer (98)
Cancer (829)
Cardiovascular disease (73)
Career advice (656)
Cell therapy (184)
Clinical research (47640)
Collaboration (334)
Compensation (84)
COVID-19 (1949)
C-suite (83)
Data (869)
Diabetes (116)
Diagnostics (5609)
Earnings (53682)
Employer resources (70)
Events (75050)
Executive appointments (236)
FDA (14672)
Funding (264)
Gene therapy (129)
GLP-1 (417)
Government (3410)
Healthcare (15466)
Infectious disease (2014)
Inflammatory bowel disease (81)
Interviews (74)
IPO (10810)
Job creations (2560)
Job search strategy (591)
Layoffs (225)
Legal (4929)
Lung cancer (138)
Manufacturing (121)
Medical device (13833)
Medtech (13838)
Mergers & acquisitions (14520)
Metabolic disorders (300)
Neuroscience (1099)
NextGen Class of 2024 (5391)
Non-profit (3389)
Northern California (1039)
Obesity (164)
Opinion (107)
Patents (83)
People (46668)
Phase I (14698)
Phase II (20833)
Phase III (16082)
Pipeline (332)
Postmarket research (1805)
Preclinical (5767)
Radiopharmaceuticals (204)
Rare diseases (144)
Real estate (4605)
Regulatory (16790)
Research institute (2071)
Resumes & cover letters (99)
Southern California (944)
Startups (3198)
United States (9982)
Vaccines (424)
Weight loss (122)
Date
Today (192)
Last 7 days (756)
Last 30 days (2794)
Last 365 days (28067)
2024 (25205)
2023 (31918)
2022 (42314)
2021 (45759)
2020 (44564)
2019 (39093)
2018 (29740)
2017 (26811)
2016 (25742)
2015 (30025)
2014 (22809)
2013 (19194)
2012 (20786)
2011 (21282)
2010 (19643)
Location
Africa (512)
Arizona (141)
Asia (33136)
Australia (5619)
California (2344)
Canada (1024)
China (202)
Colorado (112)
Connecticut (117)
Europe (70075)
Florida (365)
Georgia (98)
Illinois (272)
Indiana (153)
Kansas (94)
Maryland (498)
Massachusetts (1712)
Michigan (155)
Minnesota (219)
New Jersey (745)
New York (696)
North Carolina (562)
Northern California (1039)
Ohio (114)
Pennsylvania (586)
South America (768)
Southern California (944)
Texas (338)
Utah (75)
Washington State (285)
529,703 Results for "magnolia medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
Magnolia Medical Technologies Marks World AMR Awareness Week by Recognizing the Need to Reduce Antibiotic Usage through Accurate Blood Culture Results
In observance of World AMR Awareness Week (WAAW), Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) and the ISDD market to prevent false-positive sepsis tests, is driving efforts to highlight the role of diagnostic stewardship in combating the risk of AMR.
November 20, 2023
·
6 min read
BioForest
In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis
Magnolia Medical Technologies, Inc., the inventors of the Steripath® Initial Specimen Diversion Device® and the ISDD market, is intensifying efforts to combat sepsis misdiagnosis this Sepsis Awareness Month.
September 7, 2023
·
7 min read
Biotech Beach
USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that the US Patent and Trademark Office has rejected the relevant claims of the ‘483 patent that Magnolia Medical asserted against Kurin.
August 15, 2023
·
1 min read
Biotech Beach
Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, provided an update on the ongoing patent infringement case brought against Kurin by Magnolia Medical.
August 10, 2023
·
2 min read
Policy
USPTO Agrees to Kurin’s Request to Review Validity of Magnolia Medical’s ‘483 Patent
Kurin, Inc. announced that the US Patent and Trademark Office has granted Kurin’s Ex Parte request to reexamine the validity of U.S. Patent No. 10,039,483 that is asserted by Magnolia Medical in ongoing patent litigation.
May 3, 2023
·
2 min read
Policy
Magnolia Medical Technologies Files for Permanent Injunction Against Infringing Kurin Lock Products
Magnolia Medical Technologies, Inc. (“Magnolia Medical”) today announced it filed a motion for permanent injunction in the U.S. District Court for the District of Delaware on September 9, 2022, that would prohibit Kurin, Inc. (“Kurin”) from the continued sale of the infringing Kurin Lock products.
September 13, 2022
·
4 min read
Policy
Magnolia Medical Technologies Wins Patent-Infringement Lawsuit against Kurin, Inc.
A jury for the U.S. District Court of Delaware delivered two unanimous verdicts this week in favor of Magnolia Medical Technologies, Inc. (“Magnolia Medical”) in a lawsuit against Kurin, Inc., (“Kurin”) regarding the unlawful use of its innovative Initial Specimen Diversion Device® (ISDD®) technology.
July 29, 2022
·
3 min read
BioForest
Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance
Magnolia Medical Technologies, Inc., announced today U.S. Food and Drug Administration (FDA) 510(k) clearance of 19 new Steripath® Micro configurations within the company’s ISDD® product portfolio.
April 11, 2023
·
6 min read
BioMidwest
Delphinus Medical Technologies Announces New VP of Engineering
Delphinus Medical Technologies, a pioneering medical imaging company that developed the SoftVue™ Breast Tomographic Ultrasound, announced that Rama Gundlapalli has joined the company as Vice President of Engineering.
May 21, 2024
·
3 min read
Press Releases
Quasar Medical Acquires Ridgeback Technologies
September 26, 2024
·
2 min read
1 of 52,971
Next
